Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 4, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Tuberculosis
Interventions
DRUG

Linezolid

adjustment of Linezolid of based on the AUC/MIC and % T\> MIC for each patient to confirm the appropriateness, in light of the peak and residual, and the interest of the split doses more frequently performed in case of too low residual or toxicity.

Trial Locations (1)

91640

Sanatorium du Petit Fontainebleau Centre Médical de Bligny, Briis-sous-Forges

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT02778828 - Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis | Biotech Hunter | Biotech Hunter